Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess For The Treatment Of Recent Onset Atrial Fibrillation

drugsDecember 11, 2019

Tag: Atrial fibrillation , Brinavess , Correvio Pharma Corp.

PharmaSources Customer Service